These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 15205341)

  • 1. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
    Glunde K; Jie C; Bhujwalla ZM
    Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of choline phospholipid metabolism in ovarian tumor progression.
    Iorio E; Mezzanzanica D; Alberti P; Spadaro F; Ramoni C; D'Ascenzo S; Millimaggi D; Pavan A; Dolo V; Canevari S; Podo F
    Cancer Res; 2005 Oct; 65(20):9369-76. PubMed ID: 16230400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
    Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H
    Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
    Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
    Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.
    Glunde K; Raman V; Mori N; Bhujwalla ZM
    Cancer Res; 2005 Dec; 65(23):11034-43. PubMed ID: 16322253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
    Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
    Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.
    Aboagye EO; Bhujwalla ZM
    Cancer Res; 1999 Jan; 59(1):80-4. PubMed ID: 9892190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells.
    Glunde K; Jie C; Bhujwalla ZM
    Neoplasia; 2006 Sep; 8(9):758-71. PubMed ID: 16984733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
    Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
    Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methyl-3H]-choline incorporation into MCF-7 cells: correlation with proliferation, choline kinase and phospholipase D assay.
    Al-Saeedi F; Smith T; Welch A
    Anticancer Res; 2007; 27(2):901-6. PubMed ID: 17465218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of choline kinase by extracellular Ca2+ is Ca(2+)-sensing receptor, Galpha12 and Rho-dependent in breast cancer cells.
    Huang C; Hydo LM; Liu S; Miller RT
    Cell Signal; 2009 Dec; 21(12):1894-900. PubMed ID: 19716891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.
    Morvan D; Demidem A; Papon J; De Latour M; Madelmont JC
    Cancer Res; 2002 Mar; 62(6):1890-7. PubMed ID: 11912170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
    Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
    NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression.
    Ramírez de Molina A; Báñez-Coronel M; Gutiérrez R; Rodríguez-González A; Olmeda D; Megías D; Lacal JC
    Cancer Res; 2004 Sep; 64(18):6732-9. PubMed ID: 15374991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression.
    Natarajan K; Mori N; Artemov D; Bhujwalla ZM
    Neoplasia; 2002; 4(5):409-16. PubMed ID: 12192599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study.
    Singer S; Souza K; Thilly WG
    Cancer Res; 1995 Nov; 55(22):5140-5. PubMed ID: 7585561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells.
    Ting YL; Sherr D; Degani H
    Anticancer Res; 1996; 16(3B):1381-8. PubMed ID: 8694505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells.
    Meadows AL; Kong B; Berdichevsky M; Roy S; Rosiva R; Blanch HW; Clark DS
    Biotechnol Prog; 2008; 24(2):334-41. PubMed ID: 18307352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study.
    Daly PF; Zugmaier G; Sandler D; Carpen M; Myers CE; Cohen JS
    Cancer Res; 1990 Feb; 50(3):552-7. PubMed ID: 2153442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies.
    Eliyahu G; Kreizman T; Degani H
    Int J Cancer; 2007 Apr; 120(8):1721-30. PubMed ID: 17236204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.